Senator William Morgan Cassidy, MD chaired the hearing. The Senator’s medical career included the treatment of diseases of the liver at the Earl K. Long Medical Center (LSUMC). The Senator raised some important points such as the interchangeability between biologic and biosimilar products being consumed in the U.S., and the level of standards witnessed in foreign manufacturing plants, which leads to how the FDA proposes to address this matter.